ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
146 hedge funds and large institutions have $704M invested in iTeos Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% more funds holding
Funds holding: 143 → 146 (+3)
1% more capital invested
Capital invested by funds: $699M → $704M (+$4.97M)
1.4% less ownership
Funds ownership: 103.14% → 101.74% (-1.4%)
Holders
146
Holding in Top 10
3
Calls
$1.01M
Puts
$461K
Top Buyers
| 1 | +$8.69M | |
| 2 | +$3.17M | |
| 3 | +$2.93M | |
| 4 |
Millennium Management
New York
|
+$2.66M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.47M |
Top Sellers
| 1 | -$14.1M | |
| 2 | -$9.12M | |
| 3 | -$7.24M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.64M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$3.44M |